In an op-ed discussing the possibility of Black patients not benefiting from approval of the Alzheimer's drug lecanemab, KFF Health News quotes Jason Karlawish, who proposes the establishment of a Risk Evaluation and Mitigation Strategy by the FDA.
Citations:
"Why the Next Big Hope for Alzheimer’s Might Not Help Most Black Patients." KFF Health News, A Allen, July 6, 2023.